NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)
Close on Nov 18, 2026Market cap $104.20MP/E –Yield –
NovaBridge Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
NovaBridge Biosciences's price to sales ratio was 19.7× on Feb 28, 2025, against 28.1× a year earlier. Over the last 3 years it ranged from 5.8× to 93.5×, with a median of 27.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Feb 28, 2025 | 19.7× | +1.6 |
| 2024 | Dec 31, 2024 | 18.1× | −10.0 |
| 2023 | Feb 28, 2023 | 28.1× | +0.9 |
| 2022 | Dec 30, 2022 | 27.2× | −6.2 |
| 2020 | Oct 30, 2020 | 33.4× | – |
See a number that looks wrong?